SCHEMBL7704717

SCHEMBL7704717

O=C(Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1)N1CCN(c2ccccc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.55
CHEK1 O14757 1/20 0.53
CA12 O43570 3/20 0.52
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
CA9 Q16790 3/20 0.52
CDK1 P06493 1/20 0.49
CDK2 P24941 1/20 0.49
NAMPT P43490 7/20 0.48
ROCK2 O75116 2/20 0.48
MAPT P10636 2/20 0.48
MEN1 O00255 1/20 0.47
HCRTR1 O43613 1/20 0.47
USP2 O75604 1/20 0.47
CYP1A2 P05177 1/20 0.47
POLB P06746 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002937 0.94 CHEK1 (0.61) KDRCHEK1CA12CA1CA2
SCHEMBL6998816 0.93 GLA (0.55) KDRCHEK1CA12CA1CA2
SCHEMBL7701118 0.89 KDR (0.61) KDRCHEK1CDK1CDK2NAMPT
SCHEMBL7701734 0.89 CHEK1 (0.58) KDRCHEK1CDK1CDK2NAMPT
SCHEMBL7704101 0.88 CHEK1 (0.57) KDRCHEK1CDK1CDK2NAMPT
SCHEMBL7701651 0.87 KDM4E (0.57) KDRCHEK1CA12CA1CA2
SCHEMBL7696919 0.85 HTR1A (0.54) KDRCHEK1CA12CA1CA2
SCHEMBL7094822 0.84 KDR (0.56) KDRCHEK1CDK1CDK2NAMPT
SCHEMBL7698438 0.83 LMNA (0.58) KDRCHEK1CDK1CDK2NAMPT
SCHEMBL7002950 0.83 LMNA (0.58) KDRCHEK1CDK1CDK2NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed